PDF-Page of PRESCRIBING INFORMATION50% Dextrose Injection, USP70% Dextrose

Baxter Corporation Mississauga Ontario L5N 0C2 Canada Date of Revision uly 30Submission Control No 174149Baxter PL 146 and Viaflex are trademarks of Baxter International Inc Page of 50 Dextr. Abboject Syringe Fliptop Container Plastic Syringe Plastic Syringe only DESCRIPTION 50 Dextrose Injection USP is a sterile nonpyrogen ic hypertonic solution of dextrose in water for injection for intravenous injection as a fluid and nutrient repleni Product Summary and Explanation A basic characteristic of a microorganism is its nutritional requirements and without the proper nutrients the organism cannot survive An essential variety of ingredients are used in the preparation of dehydrated cult 1 PACKAGE INSERT free The primary container consists of a bagSame as freeThe secondary packaging is an overwrap.Same as The freeplastic container is fabricatedSfreefrom a specially formulated po E. lectrolyte Balance. There is daily fluid intake and fluid out put. *. fluid intake:. Its from two main sources. 1-Exogenous. Water is either drunk or ingested in solid food , the a average is 2-3 liters / 24 hour. Ingredients Gms / Litre Dextrose 20.000 Peptone, special Final pH ( at 25 DEXTROSE TRYPTONE AGAR (7340) Intended Use Dextrose Tryptone Agar is used for isolation of mesophilic or thermophilic spoilage microorganisms from food. Product Summary and Explanation Dextrose Try Hypoglycemia Management in the Emergency Department Silu Zuo, Pharm.D. PGY1 Pharmacy Resident UW Medicine Patient Case CC: JT is a 53 y/o female presenting to ED with profound hypoglycemia and unresponsiveness during nuclear medicine study Prolotherapy. , a “regenerative” . injection therapy. , has been reported to be effective in rigorous randomized controlled trials. . The standard injection protocol includes injections inside and around the knee . APPROVED: NCC QUALITY COMMITTEE DEPARTMENT MANUAL: DIVISION OF NEWBORN SERVICES DATE: 12th May 2014 NEWBORN USE ONLYGIVEN ON DOCTORS ORDERS ONLY HIGHER DEXTROSE CONCENTRATION SOLUTIONPREPARATIONTo ma Fresenius Kabi Canada Ltd. 165 Galaxy Blvd, Suite 100Toronto, ON M9W 0C8 Date of Revision: Mar, 2022 Submission Control Number: PRESCRIBING INFORMATION 5% Dextrose Injection Page of Dextrose Injec Date of Revision: June 11Submission Control No: Baxter, MiniBag, MiniBag Plusand Viaflexare Trademarks of Baxter International Inc. �� Page of 12 �� &#x Page 1 of 15 20 % Dextrose Injection, USP 50% Dextrose Injection, USP 70% Dextrose Injection, USP In Single Dose Partial Filled Containers IV Fluid and Nutrient Replenisher Baxter Corporation Missis ANNEXURE 1. and how to mix various solutions for creating a desired concentration of glucose in IV infusate? The formula for preparing 100 mL of fluid with a desired concentration of glucose using 5 Reference ID: 4561207 �� &#x/MCI; 0 ;&#x/MCI; 0 ;confirmed in tests in animals according to USP biological tests for plastic containers as well as by tissue culture toxicity stud